Retinal toxicity and ocular kinetics of 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in rabbits

[1]  K. Kawasaki,et al.  Intraocular kinetics of ceftazidime (Modacin). , 1992, Ophthalmic research.

[2]  T. Matsuo,et al.  Factors associated with poor visual outcome in acute retinal necrosis. , 1991, The British journal of ophthalmology.

[3]  R. Spaide,et al.  Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. , 1991, American journal of ophthalmology.

[4]  M. Niimura,et al.  Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignancies. , 1991, The Journal of antimicrobial chemotherapy.

[5]  T. Ogiwara,et al.  Phase I clinical study of YN-72 (BV-araU, brovavir). , 1990 .

[6]  H. Machida.  In vitro anti-herpes virus action of a novel antiviral agent, brovavir (BV-araU). , 1990 .

[7]  T. Yokota,et al.  Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. , 1989, Molecular pharmacology.

[8]  T. Sasaki,et al.  [Effects of vancomycin and ofloxacin on rabbit ERG in vivo]. , 1989, Nippon Ganka Gakkai zasshi.

[9]  K. Sasaki,et al.  [The influence of melanin on intraocular dynamics]. , 1988, Nippon Ganka Gakkai zasshi.

[10]  M. Blumenkranz,et al.  Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. , 1986, Ophthalmology.

[11]  H. Machida.  Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs , 1986, Antimicrobial Agents and Chemotherapy.

[12]  M. Goldberg,et al.  Vitrectomy and intravitreal antiviral drug therapy in acute retinal necrosis syndrome. Report of two cases. , 1984, Archives of ophthalmology.

[13]  T. Stelmack,et al.  Toxicity of intravitreal antiviral drugs. , 1984, Ophthalmic surgery.

[14]  H. Machida,et al.  In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds. , 1984, Antiviral research.

[15]  H. Machida,et al.  In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds. , 1984, Antiviral research.

[16]  H. Yoshino,et al.  Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils , 1981, Antimicrobial Agents and Chemotherapy.

[17]  J. Baum,et al.  Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution. , 1981, Investigative ophthalmology & visual science.

[18]  H. Yoshino,et al.  Synthesis and antiherpesviral activity of 5-C-substituted uracil nucleosides. , 1980, Nucleic acids symposium series.

[19]  T. Lawwill.  Practical rabbit electroretinography. , 1972, American journal of ophthalmology.